1161191

Apozeal Pharmaceuticals Inc. — FEI 3004536846

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
December 15, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Levittown, PA (United States)